|
Report Date : |
24.09.2013 |
IDENTIFICATION DETAILS
|
Name : |
SANOFI CHIMIE SA |
|
|
|
|
Registered Office : |
9 rue Salvador Allende Gentilly, 94250 |
|
|
|
|
Country : |
France |
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
15.12.1999 |
|
|
|
|
Com. Reg. No.: |
428706204 |
|
|
|
|
Legal Form : |
Public Subsidiary |
|
|
|
|
Line of Business : |
Manufacture of basic chemicals |
|
|
|
|
No. of Employees : |
4,136 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
France |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
FRANCE - ECONOMIC OVERVIEW
The French economy is diversified across all sectors. The
government has partially or fully privatized many large companies, including
Air France, France Telecom, Renault, and Thales. However, the government
maintains a strong presence in some sectors, particularly power, public
transport, and defense industries. With at least 79 million foreign tourists
per year, France is the most visited country in the world and maintains the
third largest income in the world from tourism. France's leaders remain
committed to a capitalism in which they maintain social equity by means of
laws, tax policies, and social spending that reduce income disparity and the
impact of free markets on public health and welfare. France's real GDP
contracted 2.6% in 2009, but recovered somewhat in 2010 and 2011, before
stagnating in 2012. The unemployment rate increased from 7.4% in 2008 to 10.3%
in 2012. Youth unemployment shot up to 24.2% during the third quarter of 2012
in metropolitan France. Lower-than-expected growth and high unemployment costs
have strained France's public finances. The budget deficit rose sharply from
3.4% of GDP in 2008 to 7.5% of GDP in 2009 before improving to 4.5% of GDP in
2012, while France's public debt rose from 68% of GDP to 89% over the same
period. Under President SARKOZY, Paris implemented some austerity measures to
bring the budget deficit under the 3% euro-zone ceiling by 2013 and to
highlight France's commitment to fiscal discipline at a time of intense
financial market scrutiny of euro-zone debt. Socialist Party candidate Francois
HOLLANDE won the May 2012 presidential election, after advocating pro-growth
economic policies, the separation of banks' traditional deposit taking and
lending activities from more speculative businesses, increasing the top
corporate and personal tax rates, and hiring an additional 60,000 teachers
during his five-year term. The government's attempt to introduce a 75% wealth
tax on income over one million euros for two years was struck down by the
French Constitutional Council in December 2012 because it applied to
individuals rather than households. France ratified the EU fiscal stability
treaty in October 2012 and HOLLANDE's government has maintained France's
commitment to meeting the budget deficit target of 3% of GDP during 2013 even
amid signs that economic growth will be lower than the government's forecast of
0.8%. Despite stagnant growth and fiscal challenges, France's borrowing costs
declined during the second half of 2012 to euro-era lows.
Source
: CIA
Sanofi Chimie SA
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||
Business
Description
|
Sanofi Chimie is primarily engaged in manufacture of other organic
basic chemicals: acyclic hydrocarbons, saturated and unsaturated; cyclic
hydrocarbons, saturated and unsaturated; acyclic and cyclic alcohols,
including synthetic ethyl alcohol; mono- and polycarboxyclic acids including
acetic acid; other oxygen-function compounds including aldehydes, ketones,
quinones and dual or poly oxygen-function compounds; nitrogen-function
organic compounds including amines; other organic compounds including wood
distillation products, etc.; manufacture of charcoal; production of pitch and
pitch coke; manufacture of synthetic aromatic products; and distillation of
coal tar. |
Industry
|
Industry |
|
|
ANZSIC 2006: |
|
|
ISIC Rev 4: |
|
|
NACE Rev 2: |
|
|
NAICS 2012: |
|
|
UK SIC 2007: |
|
|
US SIC 1987: |
2819 - Industrial Inorganic Chemicals, Not Elsewhere
Classified |
Key Executives
|
1 - Profit &
Loss Item Exchange Rate: USD 1 = EUR 0.7191895
2 - Balance Sheet Item Exchange Rate: USD 1 = EUR 0.770327
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Sanofi Chimie SA
|
|
|
|
Company Name |
Company Type |
Location |
Country |
Industry |
Sales |
Employees |
|
Parent |
Paris |
France |
Pharmaceutical Manufacturing |
46,203.2 |
111,974 |
|
|
Subsidiary |
Bridgewater, NJ |
United States |
Holding Companies |
2,700.0 |
11,400 |
|
|
Subsidiary |
Bridgewater, NJ |
United States |
Pharmaceutical Manufacturing |
|
10,000 |
|
|
Subsidiary |
Kansas City, MO |
United States |
Pharmaceutical Manufacturing |
|
|
|
|
Unit |
Malvern, PA |
United States |
Research and Development Services |
|
|
|
|
Branch |
Bridgewater, NJ |
United States |
Pharmacies and Personal Care Stores |
155.5 |
500 |
|
|
Branch |
Malvern, PA |
United States |
Research and Development Services |
|
500 |
|
|
Division |
Kansas City, MO |
United States |
Pharmaceutical Manufacturing |
299.0 |
300 |
|
|
Branch |
St Louis, MO |
United States |
Pharmacies and Personal Care Stores |
24.9 |
90 |
|
|
Subsidiary |
San Juan, PR |
United States |
Health and Personal Care Wholesale |
10.1 |
72 |
|
|
Branch |
Oro Valley, AZ |
United States |
Research and Development Services |
|
40 |
|
|
Branch |
Scottsdale, AZ |
United States |
Health and Personal Care Wholesale |
82.1 |
32 |
|
|
Subsidiary |
Atlanta, GA |
United States |
Health and Personal Care Wholesale |
37.0 |
15 |
|
|
Branch |
Reston, VA |
United States |
Health and Personal Care Wholesale |
19.6 |
8 |
|
|
Branch |
Cambridge, MA |
United States |
Pharmacies and Personal Care Stores |
2.0 |
7 |
|
|
Branch |
Wilmington, DE |
United States |
Accounting and Tax Preparation |
0.4 |
3 |
|
|
Subsidiary |
Amsterdam |
Netherlands |
Pharmaceutical Manufacturing |
|
6,000 |
|
|
Subsidiary |
Prague |
Czech Republic |
Pharmaceutical Manufacturing |
|
4,678 |
|
|
Subsidiary |
Bratislava |
Slovakia |
Pharmaceutical Manufacturing |
13.9 |
892 |
|
|
Subsidiary |
Moscow |
Russian Federation |
Professional and Commercial Equipment Wholesale |
195.8 |
716 |
|
|
Subsidiary |
MĂ¼nchen, Bayern |
Germany |
Pharmaceutical Manufacturing |
|
67 |
|
|
Subsidiary |
Istanbul |
Turkey |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Duluth, GA |
United States |
Pharmaceutical Manufacturing |
2,700.0 |
5,600 |
|
|
Subsidiary |
Lyon |
France |
Pharmaceutical Manufacturing |
1,059.4 |
1,792 |
|
|
Subsidiary |
Milano, Milano |
Italy |
Health and Personal Care Wholesale |
191.3 |
171 |
|
|
Subsidiary |
Ancenis |
France |
Metal Products Manufacturing |
36.7 |
107 |
|
|
Subsidiary |
Hallbergmoos, Bayern |
Germany |
Pharmaceutical Manufacturing |
80.9 |
90 |
|
|
Subsidiary |
Paulinia, Sao Paulo |
Brazil |
Pharmaceutical Manufacturing |
239.2 |
60 |
|
|
Subsidiary |
Singapore |
Singapore |
Health and Personal Care Wholesale |
1,440.3 |
35 |
|
|
Subsidiary |
Porto Salvo, Oeiras |
Portugal |
Health and Personal Care Wholesale |
16.5 |
27 |
|
|
Subsidiary |
Velserbroek, Noord-Holland |
Netherlands |
Metal Products Manufacturing |
|
26 |
|
|
Subsidiary |
Shinjuku-Ku, Tokyo |
Japan |
Health and Personal Care Wholesale |
78.9 |
|
|
|
Subsidiary |
Harlow |
United Kingdom |
Pharmaceutical Manufacturing |
1,312.6 |
1,246 |
|
|
Subsidiary |
Parramatta, NSW |
Australia |
Professional and Commercial Equipment Wholesale |
8.3 |
100 |
|
|
Subsidiary |
Manukau |
New Zealand |
Professional and Commercial Equipment Wholesale |
3.2 |
39 |
|
|
Subsidiary |
Tokyo |
Japan |
Professional and Commercial Equipment Wholesale |
|
|
|
|
Subsidiary |
Walpole, NH |
United States |
Crop and Animal Production |
|
810 |
|
|
Subsidiary |
Sinks Grove, WV |
United States |
Crop and Animal Production |
7.8 |
15 |
|
|
Subsidiary |
Monroe, OR |
United States |
Crop and Animal Production |
1.9 |
9 |
|
|
Subsidiary |
Duluth, GA |
United States |
Pharmaceutical Manufacturing |
19.7 |
300 |
|
|
Branch |
Athens, GA |
United States |
Pharmaceutical Manufacturing |
242.2 |
260 |
|
|
Subsidiary |
Gainesville, GA |
United States |
Pharmaceutical Manufacturing |
|
250 |
|
|
Subsidiary |
Skovlunde |
Denmark |
Food Manufacturing |
0.0 |
100 |
|
|
Subsidiary |
Barcelona |
Spain |
Pharmaceutical Manufacturing |
50.9 |
58 |
|
|
Subsidiary |
Martinez, Buenos Aires |
Argentina |
Health and Personal Care Wholesale |
33.1 |
47 |
|
|
Subsidiary |
Diegem |
Belgium |
Food Manufacturing |
23.7 |
26 |
|
|
Branch |
Fulton, MO |
United States |
Pharmaceutical Manufacturing |
10.0 |
10 |
|
|
Branch |
Roseville, CA |
United States |
Pharmaceutical Manufacturing |
9.0 |
10 |
|
|
Subsidiary |
Bogota, Cundinamarca |
Colombia |
Wood Product Manufacturing |
|
4 |
|
|
Subsidiary |
El Marques, Queretaro |
Mexico |
Food Manufacturing |
|
|
|
|
Subsidiary |
Sao Paulo |
Brazil |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Montreal, QC |
Canada |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Duluth, GA |
United States |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Antony |
France |
Pharmaceutical Manufacturing |
21.0 |
4,593 |
|
|
Subsidiary |
Paris |
France |
Basic Chemical Manufacturing |
|
|
|
|
Subsidiary |
Singapore |
Singapore |
Pharmaceutical Manufacturing |
100.3 |
25 |
|
|
Subsidiary |
Paris |
France |
Pharmaceutical Manufacturing |
1,705.1 |
3,499 |
|
|
Subsidiary |
Amman |
Jordan |
Health and Personal Care Wholesale |
|
|
|
|
Subsidiary |
Ciudad De Mexico, Distrito Federal |
Mexico |
Health and Personal Care Wholesale |
26.4 |
3,200 |
|
|
Subsidiary |
Mumbai |
India |
Pharmaceutical Manufacturing |
302.3 |
3,164 |
|
|
Subsidiary |
Paris |
France |
Pharmaceutical Manufacturing |
3,629.1 |
3,053 |
|
|
Subsidiary |
Chilly Mazarin |
France |
Research and Development Services |
1,746.5 |
5,391 |
|
|
Branch |
Strasbourg, Bas Rhin |
France |
Research and Development Services |
|
50 |
|
|
Subsidiary |
Quito, Pichincha |
Ecuador |
Health and Personal Care Wholesale |
3.4 |
50 |
|
|
Subsidiary |
Budapest |
Hungary |
Pharmaceutical Manufacturing |
1,759.2 |
2,500 |
|
|
Subsidiary |
MĂ©xico, D.F. |
Mexico |
Pharmaceutical Manufacturing |
724.1 |
2,450 |
|
|
Subsidiary |
Cambridge, MA |
United States |
Pharmaceutical Manufacturing |
4,048.7 |
2,000 |
|
|
Division |
Framingham, MA |
United States |
Pharmaceutical Manufacturing |
|
8,000 |
|
|
Division |
Cambridge, MA |
United States |
Pharmaceutical Manufacturing |
|
7,000 |
|
|
Division |
Cambridge, MA |
United States |
Pharmaceutical Manufacturing |
237.9 |
800 |
|
|
Branch |
New York, NY |
United States |
Diagnostic Laboratories |
114.2 |
600 |
|
|
Subsidiary |
Geel |
Belgium |
Pharmaceutical Manufacturing |
228.8 |
522 |
|
|
Subsidiary |
Waterford |
Ireland |
Pharmaceutical Manufacturing |
1,298.4 |
472 |
|
|
Subsidiary |
Naarden |
Netherlands |
Pharmaceutical Manufacturing |
1,089.2 |
450 |
|
|
Subsidiary |
Neu-Isenburg, Hessen |
Germany |
Health and Personal Care Wholesale |
190.4 |
185 |
|
|
Subsidiary |
Neu-Isenburg, Hessen |
Germany |
Research and Development Services |
|
|
|
|
Subsidiary |
Oxford |
United Kingdom |
Health and Personal Care Wholesale |
152.8 |
181 |
|
|
Subsidiary |
Modena |
Italy |
Pharmaceutical Manufacturing |
202.3 |
93 |
|
|
Subsidiary |
Neu-Isenburg, Hessen |
Germany |
Holding Companies |
|
1 |
|
|
Branch |
Los Angeles, CA |
United States |
Research and Development Services |
|
400 |
|
|
Subsidiary |
Ridgefield, NJ |
United States |
Pharmaceutical Manufacturing |
200.0 |
300 |
|
|
Branch |
Santa Fe, NM |
United States |
Architecture and Engineering |
|
250 |
|
|
Subsidiary |
San Antonio, TX |
United States |
Pharmaceutical Manufacturing |
|
225 |
|
|
Subsidiary |
Moscow |
Russian Federation |
Health and Personal Care Wholesale |
7.5 |
164 |
|
|
Subsidiary |
Mississauga, ON |
Canada |
Pharmaceutical Manufacturing |
109.0 |
150 |
|
|
Subsidiary |
San Antonio, TX |
United States |
Research and Development Services |
|
110 |
|
|
Subsidiary |
Phoenix, AZ |
United States |
Research and Development Services |
|
110 |
|
|
Branch |
Monrovia, CA |
United States |
Research and Development Services |
|
100 |
|
|
Division |
Framingham, MA |
United States |
Advertising Services |
|
100 |
|
|
Branch |
Waltham, MA |
United States |
Pharmaceutical Manufacturing |
75.3 |
95 |
|
|
Branch |
San Diego, CA |
United States |
Pharmaceutical Manufacturing |
50.6 |
84 |
|
|
Branch |
Allston, MA |
United States |
Pharmaceutical Manufacturing |
44.6 |
84 |
|
|
Branch |
Cambridge, MA |
United States |
Pharmaceutical Manufacturing |
44.6 |
84 |
|
|
Branch |
Framingham, MA |
United States |
Pharmaceutical Manufacturing |
44.6 |
84 |
|
|
Branch |
Framingham, MA |
United States |
Pharmaceutical Manufacturing |
44.6 |
84 |
|
|
Subsidiary |
Tokyo |
Japan |
Pharmaceutical Manufacturing |
|
70 |
|
|
Branch |
Tampa, FL |
United States |
Architecture and Engineering |
|
60 |
|
|
Subsidiary |
Copenhagen |
Denmark |
Pharmaceutical Manufacturing |
0.0 |
35 |
|
|
Subsidiary |
Zaventem |
Belgium |
Pharmaceutical Manufacturing |
41.2 |
34 |
|
|
Branch |
Exton, PA |
United States |
Pharmaceutical Manufacturing |
11.5 |
18 |
|
|
Subsidiary |
St Germain En Laye |
France |
Health and Personal Care Wholesale |
290.2 |
14 |
|
|
Subsidiary |
Lyon |
France |
Pharmaceutical Manufacturing |
207.2 |
224 |
|
|
Branch |
Philadelphia, PA |
United States |
Pharmaceutical Manufacturing |
7.7 |
12 |
|
|
Subsidiary |
Long Beach, CA |
United States |
Outpatient Care |
1.4 |
6 |
|
|
Branch |
Washington, DC |
United States |
Pharmaceutical Manufacturing |
0.9 |
3 |
|
|
Subsidiary |
Sao Paulo |
Brazil |
Pharmaceutical Manufacturing |
|
|
|
|
Branch |
Rio De Janeiro, Rio De Janeiro |
Brazil |
Professional and Commercial Equipment Wholesale |
|
|
|
|
Subsidiary |
Boulogne |
Argentina |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Porto Salvo |
Portugal |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Johannesburg, Bryanston |
South Africa |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Dubai |
United Arab Emirates |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Mexico |
Mexico |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Santiago |
Chile |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Bogota |
Colombia |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Lima |
Peru |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Vienna |
Austria |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Prague |
Czech Republic |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Paris, Saint Germain |
France |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Athens |
Greece |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Kefar Sava |
Israel |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Istanbul |
Turkey |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Gurgaon, Haryana |
India |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Seoul, KangNam-Ku |
Korea, Republic of |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Petaling Jaya, Selangor Darul Ehsan |
Malaysia |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Taipei |
Taiwan |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
North Ryde |
Australia |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Geel |
Belgium |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Madrid |
Spain |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Singapore |
Singapore |
Pharmaceutical Manufacturing |
|
|
|
|
Genzyme Australasia Pty Ltd |
Subsidiary |
|
|
|
|
|
|
Subsidiary |
Moscow |
Russian Federation |
Pharmaceutical Manufacturing |
698.7 |
1,500 |
|
|
Subsidiary |
Campinas, SP |
Brazil |
Pharmaceutical Manufacturing |
582.0 |
1,500 |
|
|
Subsidiary |
Warszawa |
Poland |
Pharmaceutical Manufacturing |
619.4 |
1,210 |
|
|
Subsidiary |
Dhaka |
Bangladesh |
Pharmaceutical Manufacturing |
|
1,200 |
|
|
Subsidiary |
Istanbul |
Turkey |
Pharmaceutical Manufacturing |
299.5 |
1,120 |
|
|
Subsidiary |
Paris |
France |
Holding Companies |
|
1,000 |
|
|
Affiliates |
Frankfurt Am Main, Hessen |
Germany |
Pharmaceutical Manufacturing |
6,599.1 |
7,600 |
|
|
Subsidiary |
Mexico |
Mexico |
Pharmaceutical Manufacturing |
|
7,000 |
|
|
Subsidiary |
Mumbai |
India |
Pharmaceutical Manufacturing |
300.0 |
3,164 |
|
|
Branch |
Mumbai, Maharashtra |
India |
Agricultural Chemical Manufacturing |
|
75 |
|
|
Branch |
Mumbai, Maharashtra |
India |
Pharmaceutical Manufacturing |
|
70 |
|
|
Subsidiary |
SĂ£o Paulo, SP |
Brazil |
Pharmaceutical Manufacturing |
1,088.0 |
2,560 |
|
|
Subsidiary |
Laval, QC |
Canada |
Pharmaceutical Manufacturing |
540.1 |
1,700 |
|
|
Subsidiary |
Saint-Laurent, QC |
Canada |
Health and Personal Care Wholesale |
120.0 |
51 |
|
|
Subsidiary |
Barcelona |
Spain |
Pharmaceutical Manufacturing |
742.9 |
1,170 |
|
|
Subsidiary |
Macquarie Park, NSW |
Australia |
Pharmaceutical Manufacturing |
597.8 |
1,000 |
|
|
Subsidiary |
Guildford |
United Kingdom |
Pharmaceutical Manufacturing |
|
500 |
|
|
Subsidiary |
Frankfurt |
Germany |
Pharmaceutical Manufacturing |
|
500 |
|
|
Subsidiary |
Bangkok |
Thailand |
Pharmaceutical Manufacturing |
|
350 |
|
|
Subsidiary |
Vienna |
Austria |
Pharmaceutical Manufacturing |
|
220 |
|
|
Subsidiary |
Gouda |
Netherlands |
Pharmaceutical Manufacturing |
|
160 |
|
|
Subsidiary |
Bromma |
Sweden |
Health and Personal Care Wholesale |
112.7 |
144 |
|
|
Subsidiary |
Budapest |
Hungary |
Pharmaceutical Manufacturing |
|
140 |
|
|
Subsidiary |
Lima |
Peru |
Pharmaceutical Manufacturing |
|
120 |
|
|
Subsidiary |
Causeway Bay |
Hong Kong |
Health and Personal Care Wholesale |
|
100 |
|
|
Subsidiary |
Lysaker |
Norway |
Pharmaceutical Manufacturing |
|
90 |
|
|
Subsidiary |
Dublin |
Ireland |
Pharmaceutical Manufacturing |
54.9 |
83 |
|
|
Subsidiary |
Quito |
Ecuador |
Pharmaceutical Manufacturing |
|
70 |
|
|
Subsidiary |
Geneva |
Switzerland |
Pharmaceutical Manufacturing |
|
11 |
|
|
Subsidiary |
Jakarta |
Indonesia |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Tokyo |
Japan |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Lainate, MI |
Italy |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Midrand |
South Africa |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Praha |
Czech Republic |
Pharmaceutical Manufacturing |
319.8 |
994 |
|
|
Subsidiary |
Bucuresti |
|
Pharmaceutical Manufacturing |
75.1 |
532 |
|
|
Subsidiary |
Cairo |
Egypt |
Pharmaceutical Manufacturing |
|
716 |
|
|
Subsidiary |
Cuautitlan Izcalli, Estado De Mexico |
Mexico |
Pharmaceutical Manufacturing |
94.6 |
600 |
|
|
Subsidiary |
Guildford |
United Kingdom |
Health and Personal Care Wholesale |
602.3 |
581 |
|
|
Subsidiary |
Guildford |
United Kingdom |
Pharmaceutical Manufacturing |
98.4 |
23 |
|
|
Subsidiary |
Shanghai |
China |
Pharmaceutical Manufacturing |
|
575 |
|
|
Subsidiary |
Makati |
Philippines |
Research and Development Services |
|
570 |
|
|
Subsidiary |
Chattanooga, TN |
United States |
Pharmaceutical Manufacturing |
463.3 |
547 |
|
|
Branch |
Coral Gables, FL |
United States |
Consulting Services |
1.0 |
5 |
|
|
Subsidiary |
Basingstoke |
United Kingdom |
Nonclassifiable Establishments |
2.4 |
4 |
|
|
Branch |
Redondo Beach, CA |
United States |
Miscellaneous Wholesale |
8.1 |
3 |
|
|
Branch |
Chattanooga, TN |
United States |
Pharmacies and Personal Care Stores |
0.6 |
2 |
|
|
Branch |
Roseville, CA |
United States |
Department Stores |
0.5 |
2 |
|
|
Subsidiary |
Jakarta |
Indonesia |
Pharmaceutical Manufacturing |
|
500 |
|
|
Subsidiary |
Casablanca |
Morocco |
Pharmaceutical Manufacturing |
|
450 |
|
|
Subsidiary |
Casablanca |
Morocco |
Pharmaceutical Manufacturing |
|
450 |
|
|
Subsidiary |
Köln, Nordrhein-Westfalen |
Germany |
Pharmaceutical Manufacturing |
174.0 |
420 |
|
|
Subsidiary |
Seoul |
Korea, Republic of |
Health and Personal Care Wholesale |
310.5 |
410 |
|
|
Subsidiary |
Virginia, QLD |
Australia |
Pharmaceutical Manufacturing |
36.2 |
400 |
|
|
Subsidiary |
San Isidro, Buenos Aires |
Argentina |
Pharmaceutical Manufacturing |
93.8 |
300 |
|
|
Subsidiary |
Vernier |
Switzerland |
Health and Personal Care Wholesale |
19,490.2 |
270 |
|
|
Subsidiary |
Kuala Lumpur |
Malaysia |
Pharmaceutical Manufacturing |
107.6 |
250 |
|
|
Subsidiary |
Guildford |
United Kingdom |
Pharmaceutical Manufacturing |
74.4 |
248 |
|
|
Subsidiary |
Kallithea, Athens |
Greece |
Pharmaceutical Manufacturing |
382.2 |
240 |
|
|
Subsidiary |
Diegem |
Belgium |
Pharmaceutical Manufacturing |
308.3 |
214 |
|
|
Subsidiary |
Vilnius |
Lithuania |
Pharmaceutical Manufacturing |
58.6 |
200 |
|
|
Subsidiary |
Prague |
Czech Republic |
Pharmaceutical Manufacturing |
|
200 |
|
|
Subsidiary |
Harlow |
United Kingdom |
Pharmaceutical Manufacturing |
124.7 |
187 |
|
|
Subsidiary |
Istanbul |
Turkey |
Pharmaceutical Manufacturing |
|
185 |
|
|
Subsidiary |
Kiev |
Ukraine |
Pharmaceutical Manufacturing |
72.5 |
150 |
|
|
Subsidiary |
Beirut |
Lebanon |
Health and Personal Care Wholesale |
|
147 |
|
|
Subsidiary |
Singapore |
Singapore |
Pharmaceutical Manufacturing |
1,281.8 |
131 |
|
|
Subsidiary |
Wien |
Austria |
Pharmaceutical Manufacturing |
151.7 |
108 |
|
|
Subsidiary |
Las Condes, Santiago |
Chile |
Pharmaceutical Manufacturing |
|
100 |
|
|
Subsidiary |
Geneva |
Switzerland |
Pharmaceutical Manufacturing |
|
100 |
|
|
Subsidiary |
Kuala Lumpur, Kuala Lumpur |
Malaysia |
Grocery Stores |
|
60 |
|
|
Subsidiary |
Bratislava |
Slovakia |
Pharmaceutical Manufacturing |
|
98 |
|
|
Subsidiary |
Dublin |
Ireland |
Pharmaceutical Manufacturing |
83.4 |
88 |
|
|
Subsidiary |
Horsholm |
Denmark |
Pharmaceutical Manufacturing |
71.0 |
85 |
|
|
Subsidiary |
Dakar |
Senegal |
Health and Personal Care Wholesale |
|
80 |
|
|
Subsidiary |
Mumbai |
India |
Pharmaceutical Manufacturing |
|
70 |
|
|
Subsidiary |
Lysaker |
Norway |
Research and Development Services |
69.4 |
59 |
|
|
Subsidiary |
Saint Laurent, QC |
Canada |
Pharmaceutical Manufacturing |
|
50 |
|
|
Subsidiary |
Saint Laurent, QC |
Canada |
Miscellaneous Chemical Manufacturing |
|
50 |
|
|
Subsidiary |
Amman |
Jordan |
Pharmaceutical Manufacturing |
|
50 |
|
|
Subsidiary |
San Diego, CA |
United States |
Research and Development Services |
|
46 |
|
|
Subsidiary |
Lagos |
Nigeria |
Health and Personal Care Wholesale |
|
40 |
|
|
Subsidiary |
Singapore |
Singapore |
Pharmaceutical Manufacturing |
166.3 |
39 |
|
|
Subsidiary |
Zagreb |
Croatia |
Pharmaceutical Manufacturing |
7.9 |
35 |
|
|
Subsidiary |
Tallinn |
Estonia |
Pharmaceutical Manufacturing |
4.6 |
35 |
|
|
Subsidiary |
Woburn, MA |
United States |
Electromedical and Control Instruments Manufacturing |
14.9 |
30 |
|
|
Subsidiary |
Montevideo |
Uruguay |
Pharmacies and Personal Care Stores |
|
30 |
|
|
Subsidiary |
Paris |
France |
Miscellaneous Chemical Manufacturing |
|
30 |
|
|
Subsidiary |
Paris |
France |
Research and Development Services |
0.0 |
28 |
|
|
Subsidiary |
Riga |
Latvia |
Pharmaceutical Manufacturing |
6.3 |
25 |
|
|
Subsidiary |
Damascus |
Syria |
Pharmaceutical Manufacturing |
|
25 |
|
|
Subsidiary |
South San Francisco, CA |
United States |
Research and Development Services |
|
20 |
|
|
Subsidiary |
Kuwait |
Kuwait |
Pharmaceutical Manufacturing |
|
15 |
|
|
Subsidiary |
Strovolos, Nicosia |
Cyprus |
Pharmaceutical Manufacturing |
|
12 |
|
|
Subsidiary |
Horsham, PA |
United States |
Pharmaceutical Manufacturing |
|
4 |
|
|
Subsidiary |
Frankfurt Am Main, Hessen |
Germany |
Holding Companies |
|
2 |
|
|
Subsidiary |
Frankfurt Am Main, Hessen |
Germany |
Pharmaceutical Manufacturing |
218.1 |
1 |
|
|
Subsidiary |
Paris |
France |
Health and Personal Care Wholesale |
734.1 |
|
|
|
Subsidiary |
Ciudad De Mexico, Distrito Federal |
Mexico |
Pharmaceutical Manufacturing |
391.2 |
|
|
|
Subsidiary |
Ciudad De Mexico, Distrito Federal |
Mexico |
Pharmaceutical Manufacturing |
|
392 |
|
|
Subsidiary |
BogotĂ¡ DC |
Colombia |
Health and Personal Care Wholesale |
236.6 |
|
|
|
Subsidiary |
Bogota, Bogota |
Colombia |
Pharmaceutical Manufacturing |
0.1 |
600 |
|
|
Subsidiary |
Paris |
France |
Health and Personal Care Wholesale |
43.5 |
|
|
|
Subsidiary |
Shanghai |
China |
Food Manufacturing |
25.5 |
|
|
|
Subsidiary |
Antony |
France |
Health and Personal Care Wholesale |
0.2 |
|
|
|
Subsidiary |
Lyon |
France |
Pharmaceutical Manufacturing |
2,045.6 |
4,500 |
|
|
Subsidiary |
Marcy-l'Etoile, Lyon |
France |
Research and Development Services |
|
8,000 |
|
|
Subsidiary |
Swiftwater, PA |
United States |
Pharmaceutical Manufacturing |
554.0 |
4,000 |
|
|
Branch |
Taylor, PA |
United States |
Health and Personal Care Wholesale |
12.4 |
5 |
|
|
Branch |
Duluth, GA |
United States |
Health and Personal Care Wholesale |
4.9 |
2 |
|
|
Subsidiary |
Lyon, Rouen |
France |
Research and Development Services |
|
1,500 |
|
|
Subsidiary |
Toronto, ON |
Canada |
Pharmaceutical Manufacturing |
12.7 |
1,100 |
|
|
Subsidiary |
North Ryde, NSW |
Australia |
Pharmaceutical Manufacturing |
|
400 |
|
|
Subsidiary |
Cambridge |
United Kingdom |
Pharmaceutical Manufacturing |
18.8 |
206 |
|
|
Subsidiary |
Cambridge, MA |
United States |
Pharmaceutical Manufacturing |
|
160 |
|
|
Subsidiary |
Taipei |
Taiwan |
Pharmaceutical Manufacturing |
|
200 |
|
|
Subsidiary |
Bucharest |
Romania |
Pharmaceutical Manufacturing |
|
200 |
|
|
Subsidiary |
San Isidro, Buenos Aires |
Argentina |
Pharmaceutical Manufacturing |
|
130 |
|
|
Subsidiary |
Manila, Makati |
Philippines |
Pharmaceutical Manufacturing |
|
70 |
|
|
Subsidiary |
Orlando, FL |
United States |
Research and Development Services |
|
70 |
|
|
Subsidiary |
Mexico |
Mexico |
Pharmaceutical Manufacturing |
|
65 |
|
|
Subsidiary |
Bangkok |
Thailand |
Pharmaceutical Manufacturing |
|
55 |
|
|
Subsidiary |
Santiago |
Chile |
Pharmaceutical Manufacturing |
|
45 |
|
|
Subsidiary |
Seoul |
Korea, Republic of |
Health and Personal Care Wholesale |
33.3 |
35 |
|
|
Subsidiary |
Istanbul |
Turkey |
Pharmaceutical Manufacturing |
|
35 |
|
|
Subsidiary |
Bogota, DC |
Colombia |
Pharmaceutical Manufacturing |
|
35 |
|
|
Subsidiary |
SĂ£o Paulo, SP |
Brazil |
Pharmaceutical Manufacturing |
|
30 |
|
|
Subsidiary |
Abidjan |
Cote d'Ivoire |
Health and Personal Care Wholesale |
|
26 |
|
|
Subsidiary |
San Isidro, Lima |
Peru |
Pharmaceutical Manufacturing |
|
20 |
|
|
Subsidiary |
Riga |
Latvia |
Pharmaceutical Manufacturing |
|
12 |
|
|
Subsidiary |
Budapest |
Hungary |
Health and Personal Care Wholesale |
|
6 |
|
|
Subsidiary |
Dubai |
United Arab Emirates |
Pharmaceutical Manufacturing |
|
4 |
|
|
Subsidiary |
Guildford |
United Kingdom |
Holding Companies |
|
2 |
|
|
Subsidiary |
Guildford |
United Kingdom |
Research and Development Services |
14.4 |
|
|
|
Subsidiary |
New Delhi |
India |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Hyderabad, |
India |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Moscow |
Russian Federation |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Beijing |
China |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Shenzhen |
China |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Tokyo |
Japan |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Kuala Lumpur |
Malaysia |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Beijing |
China |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Bratislava |
Slovakia |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Johannesburg |
South Africa |
Health and Personal Care Wholesale |
|
|
|
|
Subsidiary |
Scranton, PA |
United States |
Professional and Commercial Equipment Wholesale |
|
|
|
|
Subsidiary |
Santo Domingo |
Dominican Republic |
Chemical Wholesale |
|
|
|
|
Subsidiary |
Mixco |
Guatemala |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Lima |
Peru |
Health and Personal Care Wholesale |
|
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Holding Companies |
|
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Pharmaceutical Manufacturing |
922.2 |
458 |
|
|
Subsidiary |
Guildford |
United Kingdom |
Pharmaceutical Manufacturing |
122.6 |
383 |
|
|
Subsidiary |
Guildford |
United Kingdom |
Holding Companies |
|
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Health and Personal Care Wholesale |
|
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Holding Companies |
|
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Nonclassifiable Establishments |
|
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Nonclassifiable Establishments |
|
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Miscellaneous Professional Services |
|
|
|
|
Subsidiary |
Megrine |
Tunisia |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Taipei |
Taiwan |
Health and Personal Care Wholesale |
|
|
|
|
Subsidiary |
Dubai |
United Arab Emirates |
Health and Personal Care Wholesale |
|
|
|
|
Subsidiary |
Jakarta |
Indonesia |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Mumbai |
India |
Research and Development Services |
|
|
|
|
Subsidiary |
Jeddah |
Saudi Arabia |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Caracas, Distrito Federal |
Venezuela |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Midrand |
South Africa |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Nairobi |
Kenya |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Budapest |
Hungary |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Algiers |
Algeria |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Paris |
France |
Banking |
|
|
|
|
Subsidiary |
Paris |
France |
Banking |
|
|
|
|
Subsidiary |
Antony |
France |
Pharmaceutical Manufacturing |
14,409.5 |
5,442 |
|
|
Subsidiary |
Gentilly |
France |
Basic Chemical Manufacturing |
2,019.5 |
4,136 |
|
|
Subsidiary |
Paris |
France |
Chemical Wholesale |
169.7 |
40 |
|
|
Subsidiary |
Milano |
Italy |
Pharmaceutical Manufacturing |
1,971.3 |
2,544 |
|
|
Subsidiary |
Milano, Milano |
Italy |
Machinery Wholesale |
0.0 |
1 |
|
|
Subsidiary |
Gouda, Zuid-Holland |
Netherlands |
Miscellaneous Wholesale |
152.8 |
150 |
|
|
Subsidiary |
Gouda, Zuid-Holland |
Netherlands |
Metal Products Manufacturing |
|
6 |
|
|
Subsidiary |
Helsinki |
Finland |
Health and Personal Care Wholesale |
96.9 |
113 |
|
|
Subsidiary |
Guildford |
United Kingdom |
Holding Companies |
|
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Health and Personal Care Wholesale |
|
|
|
|
Subsidiary |
Paris |
France |
Banking |
|
|
|
|
Subsidiary |
Tegucigalpa |
Honduras |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Panama |
Panama |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Oeiras, Porto Salvo |
Portugal |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Asuncion |
Paraguay |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Ljubljana |
Slovenia |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Sofia |
Bulgaria |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Tokyo |
Japan |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Beijing |
China |
Health and Personal Care Wholesale |
|
|
|
|
Subsidiary |
Netanya |
Israel |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Sydney, NSW |
Australia |
Investment Services |
|
|
|
|
Sanofi-Aventis Healthcare Pty Ltd |
Subsidiary |
|
|
|
|
|
|
B M L Pharmaceuticals Pty Ltd |
Subsidiary |
|
|
|
|
|
|
Subsidiary |
Brisbane, QLD |
Australia |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Oeiras |
Portugal |
Health and Personal Care Wholesale |
|
|
|
|
Subsidiary |
Kuala Lumpur |
Malaysia |
Health and Personal Care Wholesale |
|
|
|
|
Subsidiary |
Almaty |
Kazakhstan |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Tbilisi |
Georgia |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Paris |
France |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Paris |
France |
Health and Personal Care Wholesale |
|
|
|
|
Subsidiary |
Porto Salvo, Lisboa |
Portugal |
Pharmaceutical Manufacturing |
131.4 |
297 |
|
|
Subsidiary |
Sofia |
Bulgaria |
Health and Personal Care Wholesale |
58.9 |
275 |
|
|
Subsidiary |
Frankfurt Am Main, Hessen |
Germany |
Holding Companies |
|
4 |
|
|
Subsidiary |
Durban, Kwazulu-Natal |
South Africa |
Basic Chemical Manufacturing |
|
1,450 |
|
|
Branch |
Mumbai, Maharashtra |
India |
Synthetic Chemical Manufacturing |
|
353 |
|
|
Subsidiary |
Frankfurt Am Main, Hessen |
Germany |
Real Estate Agents and Brokers |
|
14 |
|
|
Subsidiary |
Frankfurt Am Main, Hessen |
Germany |
Holding Companies |
|
3 |
|
|
Subsidiary |
Frankfurt Am Main, Hessen |
Germany |
Synthetic Chemical Manufacturing |
|
3 |
|
|
Subsidiary |
Abidjan |
Cote d'Ivoire |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Dakar |
Senegal |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Beijing |
China |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Wilmington, DE |
United States |
Investment Services |
|
|
|
|
Subsidiary |
Orel |
Russian Federation |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Tangshan |
China |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
San Jose |
Costa Rica |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Algiers |
Algeria |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Beijing |
China |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Budapest |
Hungary |
Agricultural Chemical Manufacturing |
|
|
|
|
Subsidiary |
Algiers |
Algeria |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Prague |
Czech Republic |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Panama |
Panama |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Hong Kong |
Hong Kong |
Pharmaceutical Manufacturing |
|
|
|
|
Subsidiary |
Paris |
France |
Research and Development Services |
|
|
Executives
Report
|
|
|
31-Dec-2011 |
31-Dec-2010 |
31-Dec-2009 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate
(Period Average) |
0.71919 |
0.755078 |
0.719047 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Total income |
2,304.9 |
2,434.4 |
1,999.3 |
|
Net sales |
2,019.5 |
2,146.6 |
1,804.1 |
|
Change in stock |
1.1 |
26.2 |
6.5 |
|
Unfinished work in progress |
-13.9 |
137.4 |
63.2 |
|
Own work capitalised |
24.2 |
5.1 |
5.0 |
|
Subsidies for operating costs |
0.6 |
0.7 |
0.5 |
|
Supplementary operating income |
271.2 |
143.0 |
127.0 |
|
Other operating income |
3.3 |
1.6 |
-0.6 |
|
Other external charges |
373.5 |
328.2 |
365.8 |
|
Cost of goods sold |
1,010.3 |
1,251.9 |
804.3 |
|
Taxes and social security costs |
48.3 |
48.7 |
55.3 |
|
Social charges |
170.0 |
151.4 |
154.7 |
|
Total payroll costs |
337.1 |
265.4 |
278.9 |
|
Cost of stock depreciation and amortisation |
120.5 |
229.4 |
106.8 |
|
Fixed asset depreciation and amortisation |
213.8 |
199.9 |
171.8 |
|
Other operating costs |
1.5 |
9.8 |
-0.9 |
|
Total operating costs |
2,276.1 |
2,510.9 |
1,943.1 |
|
Net operating income |
28.8 |
-76.5 |
56.2 |
|
Joint venture results |
2.6 |
8.4 |
5.6 |
|
Total financial income |
10.1 |
12.3 |
7.2 |
|
Interest payable on loans |
5.7 |
2.2 |
1.3 |
|
Other expenses |
31.4 |
17.9 |
13.8 |
|
Total expenses |
37.1 |
20.1 |
15.0 |
|
Profit before tax |
4.5 |
-76.0 |
53.9 |
|
Extraordinary income |
36.9 |
32.4 |
83.1 |
|
Extraordinary expenses |
161.6 |
276.8 |
48.5 |
|
Extraordinary result |
-124.7 |
-244.4 |
34.6 |
|
Total taxation |
-20.8 |
-14.6 |
-23.2 |
|
Profit distributed to employees |
37.9 |
34.6 |
35.0 |
|
Net profit |
- |
- |
76.7 |
|
Net loss |
137.4 |
340.4 |
- |
|
Annual Balance
Sheet |
|
Financials in:
USD (mil) |
|
|
31-Dec-2011 |
31-Dec-2010 |
31-Dec-2009 |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.770327 |
0.745406 |
0.696986 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Issued capital |
681.3 |
704.0 |
752.9 |
|
Share premium account |
247.5 |
255.8 |
273.6 |
|
Legal reserves |
246.7 |
252.1 |
267.8 |
|
Total reserves |
13.4 |
13.9 |
10.9 |
|
Profits for the year |
-128.2 |
-344.8 |
79.2 |
|
Profit brought forward from previous year(s) |
-331.7 |
2.0 |
47.4 |
|
Capital subsidies and grants |
3.7 |
4.6 |
5.3 |
|
Total stockholders equity |
732.7 |
887.6 |
1,437.1 |
|
Provisions and allowances |
793.5 |
770.6 |
417.2 |
|
Trade creditors |
195.6 |
243.4 |
229.1 |
|
Bank loans and overdrafts |
1.0 |
0.6 |
0.3 |
|
Other loans |
494.7 |
445.3 |
1.9 |
|
Other liabilities |
14.0 |
14.6 |
322.4 |
|
Debts on fixed assets |
13.5 |
56.9 |
22.6 |
|
Taxation and social security |
165.7 |
153.7 |
177.2 |
|
Total current liabilities |
884.4 |
- |
752.6 |
|
Total debts |
884.6 |
914.6 |
753.3 |
|
Regularisation account |
1.2 |
0.4 |
0.1 |
|
Total liabilities (including net worth) |
2,412.0 |
2,573.2 |
2,607.7 |
|
Patents |
6.9 |
- |
6.2 |
|
Other intangibles |
1.3 |
7.4 |
0.6 |
|
Land |
38.3 |
35.3 |
39.7 |
|
Buildings |
160.3 |
223.1 |
252.4 |
|
Other fixed assets |
783.6 |
768.0 |
774.7 |
|
Long-term investments |
19.2 |
19.9 |
21.3 |
|
Other financial assets |
2.5 |
3.5 |
4.6 |
|
Total non-current assets |
1,012.2 |
1,057.2 |
1,099.5 |
|
Prepayments |
0.1 |
19.1 |
25.7 |
|
Net stocks and work in progress |
908.0 |
895.2 |
786.2 |
|
Trade debtors |
388.9 |
515.2 |
618.7 |
|
Other receivables |
98.2 |
82.7 |
73.8 |
|
Prepaid expenses |
2.7 |
2.6 |
2.3 |
|
Cash and liquid assets |
0.7 |
0.1 |
0.8 |
|
Total current assets |
1,398.5 |
1,515.0 |
1,507.5 |
|
Prepaid expenses and deferred costs |
1.3 |
1.0 |
0.8 |
|
Total assets |
2,412.0 |
2,573.2 |
2,607.7 |
|
Annual Ratios |
|
Financials in:
USD (mil) |
|
|
31-Dec-2011 |
31-Dec-2010 |
31-Dec-2009 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.770327 |
0.745406 |
0.696986 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Current ratio |
1.60 |
- |
2.00 |
|
Quick ratio |
0.60 |
- |
1.00 |
|
Total liabilities to net worth |
1.22% |
1.04% |
0.53% |
|
Net worth to total assets |
0.30% |
0.34% |
0.55% |
|
Collection period |
62.60 |
71.90 |
100.90 |
|
Stock turnover rate |
2.10 |
2.40 |
2.40 |
|
Asset turnover |
0.78% |
0.85% |
0.71% |
|
Profit margin |
0.00% |
-0.04% |
0.03% |
|
Return on assets |
0.00% |
-0.03% |
0.02% |
|
Shareholders' return |
0.01% |
-0.09% |
0.04% |
|
Sales per employee |
2,303.50 |
2,530.25 |
1,992.39 |
|
Profit per employee |
5.08 |
-89.60 |
59.54 |
|
Average wage per employee |
384.49 |
312.87 |
307.97 |
|
Net worth |
732.7 |
887.6 |
1,437.1 |
|
Number of employees |
4,136 |
4,202 |
4,271 |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.52 |
|
|
1 |
Rs.100.26 |
|
Euro |
1 |
Rs.84.67 |
INFORMATION DETAILS
|
Report
Prepared by : |
NIT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.